Suppr超能文献

多囊卵巢综合征女性与不明原因不孕症女性中阿法蛋白、阿朴脂蛋白和五聚体3水平的比较分析

Comparative Analysis of Afamin, Asprosin, and Pentraxin 3 Levels in Women with PCOS and Women with Unexplained Infertility.

作者信息

Derici Mehmet Kursat, Yıldırım Engin

机构信息

Department of Medical Pharmacology, Gulhane Faculty of Medicine, University of Health Sciences, Ankara, Turkey.

Department of Obstetrics and Gynecology, Faculty of Medicine, Malatya Turgut Özal University, Malatya, Turkey.

出版信息

Med Sci Monit. 2025 Jul 4;31:e947895. doi: 10.12659/MSM.947895.

Abstract

BACKGROUND Infertility is defined as the absence of pregnancy despite unprotected, regular sexual intercourse of couples of reproductive age for at least 1 year. Infertility may be unexplained or linked to anovulation/polycystic ovary syndrome (PCOS). PCOS can involve the processes of inflammation, insulin resistance, and metabolic syndrome. This study compared serum levels of afamin, asprosin, and pentraxin3 (PTX3) between women with PCOS and women with unexplained infertility to elucidate underlying pathophysiological mechanisms. MATERIAL AND METHODS Our study included 106 women: 55 with unexplained infertility and 51 with PCOS. Using the electrochemiluminescence immunoassay method, we assessed the levels of estradiol, follicle-stimulating hormone, luteinizing hormone, and anti-Mullerian hormone. Afamin, asprosin, and PTX3 levels were measured by ELISA. RESULTS Age, fasting glucose levels, and body mass index (BMI) of the groups were statistically similar. Anti-Mullerian hormone, antral follicle count, and LH levels were higher (P<0.05) in the PCOS group. Afamin and PTX3 levels were higher in the PCOS group (P<0.05), while asprosin levels were similar. CONCLUSIONS Our study demonstrates the importance of afamin associated with oxidative stress and the PTX3, which plays a role in the regulation of humoral immune responses, in the etiology of infertility cases. Afamin and PTX3 should be evaluated in ovulatory and non-ovulatory PCOS cycles to facilitate treatment and to elucidate the ovulation and implantation processes in PCOS. These recommendations specifically include dividing PCOS patients into subgroups such as diabetogenic, obese, and hirsute, and re-examining biochemical markers accordingly.

摘要

背景

不孕症的定义是育龄夫妇在未采取保护措施、规律进行性生活至少1年后仍未怀孕。不孕症可能原因不明,或与无排卵/多囊卵巢综合征(PCOS)有关。PCOS可能涉及炎症、胰岛素抵抗和代谢综合征等过程。本研究比较了PCOS女性和不明原因不孕症女性血清中载脂蛋白A、脂肪因子和五聚体3(PTX3)的水平,以阐明潜在的病理生理机制。

材料与方法

我们的研究纳入了106名女性:55名不明原因不孕症患者和51名PCOS患者。采用电化学发光免疫分析法,我们评估了雌二醇、促卵泡激素、促黄体生成素和抗苗勒管激素的水平。通过酶联免疫吸附测定法测量载脂蛋白A、脂肪因子和PTX3的水平。

结果

两组的年龄、空腹血糖水平和体重指数(BMI)在统计学上相似。PCOS组的抗苗勒管激素、窦卵泡计数和促黄体生成素水平较高(P<0.05)。PCOS组的载脂蛋白A和PTX3水平较高(P<0.05),而脂肪因子水平相似。

结论

我们的研究表明,载脂蛋白A与氧化应激相关,PTX3在体液免疫反应调节中起作用,它们在不孕症病因中具有重要意义。应在PCOS的排卵和非排卵周期中评估载脂蛋白A和PTX3,以促进治疗并阐明PCOS的排卵和着床过程。这些建议具体包括将PCOS患者分为致糖尿病型、肥胖型和多毛型等亚组,并相应地重新检查生化标志物。

相似文献

5
In vitro maturation in subfertile women with polycystic ovarian syndrome undergoing assisted reproduction.
Cochrane Database Syst Rev. 2025 Feb 6;2(2):CD006606. doi: 10.1002/14651858.CD006606.pub5.
6
Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome.
Cochrane Database Syst Rev. 2000(4):CD000410. doi: 10.1002/14651858.CD000410.
7
Anti-Müllerian hormone as a diagnostic and prognostic marker in polycystic ovary syndrome: a clinical study.
Cell Mol Biol (Noisy-le-grand). 2025 Jul 6;71(6):30-34. doi: 10.14715/cmb/2025.71.6.4.
8
Gonadotropins for ovulation induction in women with polycystic ovary syndrome.
Cochrane Database Syst Rev. 2025 Apr 7;4(4):CD010290. doi: 10.1002/14651858.CD010290.pub4.
9
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.
Cochrane Database Syst Rev. 2022 Sep 27;9(9):CD010287. doi: 10.1002/14651858.CD010287.pub4.
10
Does metformin improve reproduction outcomes for non-obese, infertile women with polycystic ovary syndrome? Meta-analysis and systematic review.
Eur J Obstet Gynecol Reprod Biol. 2022 Apr;271:38-62. doi: 10.1016/j.ejogrb.2022.01.025. Epub 2022 Feb 1.

本文引用的文献

1
Relationship of asprosin and diabetes: a meta-analysis.
BMC Endocr Disord. 2025 Jan 23;25(1):15. doi: 10.1186/s12902-025-01843-1.
2
Biomarkers in coronary artery disease: systematic review and meta-analysis.
Future Cardiol. 2025 Jan;21(1):39-46. doi: 10.1080/14796678.2024.2442214. Epub 2025 Jan 15.
4
Evidence-based guideline: unexplained infertility†.
Hum Reprod. 2023 Oct 3;38(10):1881-1890. doi: 10.1093/humrep/dead150.
5
Serum afamin levels in predicting gestational diabetes mellitus and preeclampsia: A systematic review and meta-analysis.
Front Endocrinol (Lausanne). 2023 Mar 22;14:1157114. doi: 10.3389/fendo.2023.1157114. eCollection 2023.
6
Asprosin in health and disease, a new glucose sensor with central and peripheral metabolic effects.
Front Endocrinol (Lausanne). 2023 Jan 5;13:1101091. doi: 10.3389/fendo.2022.1101091. eCollection 2022.
7
Elevated ovarian pentraxin 3 in polycystic ovary syndrome.
J Assist Reprod Genet. 2021 May;38(5):1231-1237. doi: 10.1007/s10815-021-02105-4. Epub 2021 Feb 16.
8
Characteristics of polycystic ovary syndrome throughout life.
Ther Adv Reprod Health. 2020 Mar 18;14:2633494120911038. doi: 10.1177/2633494120911038. eCollection 2020 Jan-Dec.
9
The serum level of irisin, but not asprosin, is abnormal in polycystic ovary syndrome patients.
Sci Rep. 2019 Apr 23;9(1):6447. doi: 10.1038/s41598-019-42061-9.
10
Asprosin: a novel peptide hormone related to insulin resistance in women with polycystic ovary syndrome.
Gynecol Endocrinol. 2019 Mar;35(3):220-223. doi: 10.1080/09513590.2018.1512967. Epub 2018 Oct 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验